Christian Behrenbruch

Chief Executive, Managing Director / Telix Pharmaceuticals

Dr Christian Behrenbruch has over 20 years of healthcare entrepreneurship and executive leadership experience.

Dr Behrenbruch was the chief executive and executive director of capacity at Mirada Solutions, CTI Molecular Imaging (now Siemens Healthcare), Fibron Technologies and ImaginAb. He was also a director of Momentum Biosciences LLC, Siemens Molecular Imaging, Radius Health (now Adaptix), and former chair of Cell Therapies (a partnership with the Peter MacCallum Cancer Centre).

Lists and Charts

Roles

2017

Chief Executive, Managing Director

Telix Pharmaceuticals

Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
86^th	AVJennings	148.01%	6.57%
87^th	Yandal Resources	147.18%	-1.45%
88^th	Telix Pharmaceuticals	145.44%	70.94%
89^th	Regis Healthcare	144.9%	21.15%
90^th	Artrya	144.41%	0%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

NEW ROLE: Chief Executive, Managing Director, Telix Pharmaceuticals

03 Nov 2020

Related Information

Access to our data for Christian Behrenbruch is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Christian Behrenbruch is linked to 2 organisations which are included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.